The detection of well known pathogenic mutations in sporadic cases of GC that do not meet HDGC criteria (Garziera et al. 2013), supports the importance of searching for CDH1 mutations in this type of cancer, not only to better understand the molecular basis underlying the disease, but also to improve genetic testing and therefore the clinical management of patients and families at risk. Here, CDH1 is linked to gastric cancer.